Viking Therapeutics, Up 62% Since August, Undercuts A Buy Zone Despite Key Win

Stocks To Watch: Viking Therapeutics Sees Relative Strength Rating Rise To 89 11/18/2025Viking Therapeutics sees its Relative Strength Rating enter the 80-plus level. BREAKING: Futures Rise After Market Sell-Off Viking Therapeutics (VKTX) stock tumbled Wednesday after the biotech company said it over-enrolled one of its final-phase studies for weight-loss shot VK2735. The company was angling to enroll 4,500 patients who are overweight or have obesity with at least one related condition. Instead, Viking sign ...